These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36695948)

  • 21. APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
    Hays T; Wyatt CM
    Kidney Int; 2012 Aug; 82(3):259-60. PubMed ID: 22791322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Changing Face of Human Immunodeficiency Virus-Mediated Kidney Disease.
    Sury K; Perazella MA
    Adv Chronic Kidney Dis; 2019 May; 26(3):185-197. PubMed ID: 31202391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
    Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
    Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-associated nephropathy in the era of antiretroviral therapy.
    Wyatt CM; Klotman PE
    Am J Med; 2007 Jun; 120(6):488-92. PubMed ID: 17524746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus infection and kidney disease.
    Hilton R
    J R Coll Physicians Edinb; 2013; 43(3):236-9; quiz 240. PubMed ID: 24087804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating HIV-associated nephropathy from antiretroviral drug-induced nephropathy: a clinical challenge.
    Kumar N; Perazella MA
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):202-11. PubMed ID: 24924830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-related nephropathy: new aspects of an old paradigm.
    Reghine ÉL; Foresto RD; Kirsztajn GM
    Rev Assoc Med Bras (1992); 2020 Jan; 66Suppl 1(Suppl 1):s75-s81. PubMed ID: 31939539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.
    Mikulak J; Oriolo F; Portale F; Tentorio P; Lan X; Saleem MA; Skorecki K; Singhal PC; Mavilio D
    Retrovirology; 2016 Sep; 13(1):63. PubMed ID: 27599995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction: APOL1-Associated Kidney Disease.
    Pollak MR
    Semin Nephrol; 2017 Nov; 37(6):489. PubMed ID: 29110755
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy.
    Foy MC; Estrella MM; Lucas GM; Tahir F; Fine DM; Moore RD; Atta MG
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1524-32. PubMed ID: 23685946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOL1 localization in normal kidney and nondiabetic kidney disease.
    Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
    J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute kidney injury in patients with human immunodeficiency virus infection.
    Cohen SD; Chawla LS; Kimmel PL
    Curr Opin Crit Care; 2008 Dec; 14(6):647-53. PubMed ID: 19005305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-associated nephropathy: pathogenesis.
    Medapalli RK; He JC; Klotman PE
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):306-11. PubMed ID: 21358326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
    Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
    Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.
    Fine DM; Perazella MA; Lucas GM; Atta MG
    Drugs; 2008; 68(7):963-80. PubMed ID: 18457462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV associated kidney diseases: Clarifying concordance between renal failure in HIV infection and histopathologic manifestations at kidney biopsy.
    Ellis CL
    Semin Diagn Pathol; 2017 Jul; 34(4):377-383. PubMed ID: 28578979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
    Freedman BI; Limou S; Ma L; Kopp JB
    Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S8-S16. PubMed ID: 30343724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular pathogenesis of HIV-1 associated nephropathy: recent advances.
    Papeta N; Sterken R; Kiryluk K; Kalyesubula R; Gharavi AG
    J Mol Med (Berl); 2011 May; 89(5):429-36. PubMed ID: 21221512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical and histological response of HIV-associated kidney disease to antiretroviral therapy in South Africans.
    Fabian J; Naicker S; Goetsch S; Venter WD
    Nephrol Dial Transplant; 2013 Jun; 28(6):1543-54. PubMed ID: 23444185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The potential nephrotoxicity of antiretroviral drugs].
    Marchewka Z; Szymańska B; Płonka J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():603-8. PubMed ID: 23001202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.